Jenny Yaohua Xue, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins p21(ras) | 6 | 2023 | 1692 | 1.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2021 | 2043 | 0.470 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5534 | 0.230 |
Why?
|
| Mutation | 4 | 2023 | 29786 | 0.210 |
Why?
|
| Neoplasms | 5 | 2023 | 21696 | 0.200 |
Why?
|
| RGS Proteins | 1 | 2021 | 77 | 0.200 |
Why?
|
| GTP Phosphohydrolases | 2 | 2021 | 508 | 0.200 |
Why?
|
| Guanosine Triphosphate | 1 | 2021 | 321 | 0.190 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2019 | 54 | 0.180 |
Why?
|
| Adaptation, Biological | 1 | 2020 | 153 | 0.170 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 250 | 0.160 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 335 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2021 | 5172 | 0.150 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 13693 | 0.150 |
Why?
|
| Mutagenesis | 1 | 2019 | 1264 | 0.130 |
Why?
|
| Quinolines | 1 | 2019 | 732 | 0.120 |
Why?
|
| Cisplatin | 1 | 2019 | 1662 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3554 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2023 | 23404 | 0.090 |
Why?
|
| Mice, Nude | 3 | 2021 | 3689 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 16690 | 0.090 |
Why?
|
| Nucleotides | 2 | 2023 | 464 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2725 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 3799 | 0.080 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13104 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2023 | 3702 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5223 | 0.060 |
Why?
|
| Acetonitriles | 1 | 2021 | 53 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2021 | 138 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5511 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2021 | 682 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2023 | 1802 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 625 | 0.040 |
Why?
|
| Autocrine Communication | 1 | 2019 | 171 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 647 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2019 | 220 | 0.040 |
Why?
|
| Mice | 5 | 2023 | 81201 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 581 | 0.040 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2019 | 486 | 0.030 |
Why?
|
| Cell Division | 1 | 2023 | 4569 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1656 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1525 | 0.030 |
Why?
|
| Humans | 8 | 2021 | 744366 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1915 | 0.030 |
Why?
|
| Body Weight | 1 | 2023 | 4671 | 0.030 |
Why?
|
| Animals | 5 | 2023 | 168768 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6313 | 0.020 |
Why?
|
| Piperazines | 1 | 2021 | 2488 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5895 | 0.020 |
Why?
|
| Pyridines | 1 | 2021 | 2825 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2021 | 2943 | 0.020 |
Why?
|
| DNA Damage | 1 | 2019 | 2432 | 0.020 |
Why?
|
| Cell Survival | 1 | 2019 | 5882 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 16000 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7914 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7882 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10483 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8432 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9724 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29060 | 0.010 |
Why?
|
| Female | 2 | 2021 | 380193 | 0.010 |
Why?
|